In patients with metastatic RCC who have had a complete response to pembrolizumab and axitinib and undergone a nephrectomy, how long would you continue therapy post-operatively?  

Would you treat until progression or for a defined "adjuvant" course after nephrectomy?



Answer from: Medical Oncologist at Academic Institution